Faculty, Staff and Student Publications

Language

English

Publication Date

4-1-2022

Journal

Journal of Pediatrics

DOI

10.1016/j.jpeds.2021.12.025

PMID

34952008

PMCID

PMC8691954

PubMedCentral® Posted Date

December 2021

PubMedCentral® Full Text Version

Post-print

Abstract

In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.

Keywords

Adolescent, COVID-19, COVID-19 Vaccines, Humans, Myocarditis, RNA, Messenger

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.